6 years ago

HANOI, Vietnam--(BUSINESS WIRE)--FPT, Vietnam’s largest IT service provider, has signed a strategic partnership agreement with Quebec-based research centre Mila in…

Takeda Provides Updates on its Hemophilia Studies at WFH 2020, Reinforcing its Commitment to Putting Patients First and Supporting Personalized Care for People with Bleeding Disorders

6 years ago

− These Data Demonstrate Breadth of Takeda’s Portfolio and Pipeline with Three Hematology Presentations at the Virtual Summit OSAKA, Japan--(BUSINESS…

Solasia Announces Positive Results of DARINAPARSIN in Pivotal Phase 2 Study for Peripheral T-Cell Lymphoma

6 years ago

- The primary endpoint (antitumor effect) was achieved - No new safety concerns were identified in the safety analysis - This study was…

Mitsubishi Electric Announces End of Production of TFT-LCD Modules

6 years ago

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will end the production of TFT-LCD modules manufactured by its…

AVITA Medical Limited Proposed Redomiciliation to the United States of America – Results of Scheme Meeting

6 years ago

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that shareholders today…

BORN Group Extends Its Partnership With Akeneo Globally, to Augment Its Experience Management & Enterprise Commerce Offerings

6 years ago

Tapped as BORN’s exclusive PIM partner, Akeneo’s Product Experience Management (PXM) capabilities well complement BORN’s award-winning digital omnichannel enterprise commerce…

6 years ago

HONG KONG--(BUSINESS WIRE)--Recently, FPS+Roguelite game Gunfire Reborn developed by Duoyi (Hong Kong) Interactive starts Early Access on Steam. Upon release,…

dbExpress Drivers Now Support RAD Studio 10.4 Sydney

6 years ago

Devart rolled out the updated versions of dbExpress drivers with support for the newly released RAD Studio 10.4 Sydney. Prague,…

6 years ago

Data from a Phase II trial show a regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) was well tolerated…

BrainChip Successfully Launches the Akida Early Access Program

6 years ago

ALISO VIEJO, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN), a leading provider of Ultra-Low Power, high performance AI technology, today announced…

Show more Posts
Show previous Posts